Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Kensey Nash Corporation

Founders John E. Nash Kenneth R. Kensey

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Portfolio companies 1
Rounds per year 0.03
Lead investments 0
Key employees Soon

Areas of investment

  • Manufacturing
  • Medical Device
  • Wellness
  • Biotechnology
  • Medical
Summary

In 1984 was created Kensey Nash Corporation, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Exton. The venture was found in North America in United States.

The usual cause for the fund is to invest in rounds with 1 partaker. Despite the Kensey Nash Corporation, startups are often financed by Matignon Technologies.

Among the most popular portfolio startups of the fund, we may highlight Orteq. We can highlight the next thriving fund investment areas, such as Health Care, Medical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2011.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Kensey Nash Corporation:
Typical Co-investors
Kensey Nash Corporation is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Kensey Nash Corporation:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anblicks -
Beijing Hongshan Shiji Touzi Youxian Gongsi Beijing, Beijing, China
Candou Ventures California, Palo Alto, United States
Caribou Property -
Edelweiss Alternative Asset Advisors -
Efficient Corporate Columbus, Ohio, United States
Excelpoint Technology Central, Central Region, Singapore
Fondo de Capital Privado (FCP) -
Fox Interactive Media Beverly Hills, California, United States
Global Trust Fund Las Vegas, Nevada, United States
HuoMao TV China, Shanghai
IDEA Northeastern University's Venture Accelerator Boston, Massachusetts, United States
Kinara Indonesia, Jakarta, Jakarta Raya
Krypital Group Cayman Islands, Grand Cayman
Mingyuan Hongqiao Investment Management China, Fujian, Xiamen
R. B. Webber & Co. California, Mountain View, United States
Shenzhen Lanshi Venture Capital China, Guangdong, Shenzhen
Sylebra Capital -
Trifecta Capital California, San Francisco, United States
Unocal Corporation California, San Ramon, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Kensey Nash Corporation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Rounds per year 0.03
Peak activity year 2011
Lead investments 0
Crunchbase icon

Content report

The following text will be sent to our editors: